Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer

By Zhang Tianqian  

Cancer Immunology, Immunotherapy, Vol. 58, Iss. 4, 2009-04 ,pp. : 475-492

Springer Publishing Company

Access to resources Recommend Favorite

Differential Responses to Chemoimmunotherapy in Patients with Metastatic Malignant Melanoma

By Mainwaring P.N.   Atkinson H.   Chang J.   Moore J.   Hancock B.W.   Guillou P.J.   Oskam R.   Gore M.E.  

European Journal of Cancer, Vol. 33, Iss. 9, 1997-08 ,pp. : 1388-1392

Elsevier

Access to resources Recommend Favorite

Immunotherapy with histamine and interleukin 2 in malignant melanoma with liver metastasis

By Agarwala Sanjiv   Hellstrand Kristoffer   Gehlsen Kurt   Naredi Peter  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 9, 2004-09 ,pp. : 840-841

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Activity of Celecoxib in Metastatic Malignant Melanoma

By Wilson Kenneth  

Cancer Investigation, Vol. 24, Iss. 8, 2006-10 ,pp. : 740-746

Informa Healthcare

Access to resources Recommend Favorite

Metastatic Patterns, Clinical Outcome, and Malignant Phenotype in Malignant Cutaneous Melanoma

By Cohn-Cedermark Gabriella   Månsson-Brahme Eva   Rutqvist Lars Erik   Larsson Olle   Singnomklao Toom   Ringborg Ulrik  

Acta Oncologica, Vol. 38, Iss. 5, 1999-06 ,pp. : 549-558

Informa Healthcare

Access to resources Recommend Favorite